GLENMARK PHARMACEUTICALS LTD. - Press Release

Sub:- Glenmark Pharmaceuticals receives tentative ANDA approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg and 150 mg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Thanking You. Yours faithfully, For Glenmark Pharmaceuticals Ltd. Harish Kuber Company Secretary & Compliance Officer